Phase-I-Reaktionen: Reduktionsreaktionen

Reductive reactions introduce electrons to drug molecules, modifying lipophilic drugs by introducing or revealing polar functional groups. Enzymes called reductases catalyze these reactions, transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. This process is essential for drug detoxification and elimination from the body.

Carbonyl group reduction is an essential reductive reaction where aldehydes and ketones are reduced to alcohols. For example, naltrexone transforms into its isomorphine derivative through this process. Enzymes like aldehyde dehydrogenase catalyze the conversion of acetaldehyde to ethanol, demonstrating how carbonyl compounds are enzymatically reduced to their alcohol forms.

Carbon-carbon double bonds are reduced to single bonds through enzymatic processes. Steroids like norethindrone undergo C=C reductions, converting their double bonds into single bonds. Enzymes like cytochrome P450 reductase catalyze these transformations, making drugs more water-soluble for subsequent biotransformation or conjugation.

Nitro groups are reduced to amino groups through nitroreductase enzymes, proceeding via nitroso and hydroxylamine intermediates. For instance, nitrazepam undergoes nitro reduction to yield an amine. Azo compounds like prontosil are reduced by azoreductases to active metabolites such as sulfanilamide, demonstrating how N-compounds transform during drug metabolism.

N-oxide reductions convert N-oxide groups to their reduced forms, representing an important class of reductive reactions. Imipramine N-oxide is converted to imipramine through this process. These reductions help modify drug structure and enhance water solubility, facilitating subsequent phase II conjugation reactions for drug elimination.

Miscellaneous reductive reactions encompass various reduction processes beyond carbonyl and double bond modifications. The anesthetic halothane undergoes reductive dehalogenation, converting to trifluoroacetic acid or its derivatives. These diverse reductive pathways demonstrate how different functional groups can be modified through enzymatic reduction to facilitate drug detoxification.

Reductive reactions introduce or reveal polar functional groups on drug molecules, creating reactive sites for subsequent biotransformation or conjugation. By converting lipophilic drugs into more polar, water-soluble metabolites, these reactions facilitate the action of phase II enzymes. This sequential modification process is critical for complete drug metabolism and efficient elimination from the body.